The venture was found in North America in United States. The main department of described VC is located in the Hollywood.
Among the most popular portfolio startups of the fund, we may highlight Kyma Medical Technologies, Azura Ophthalmics. The fund has no exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Information Technology, Biotechnology. For fund there is no match between the location of its establishment and the land of its numerous investments - Israel.
The standard case for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are TPG Biotech, OrbiMed, Medical Research Commercialisation Fund (MRCF).
The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2015. The common things for fund are deals in the range of 10 - 50 millions dollars.
The overall number of key employees were 2.
Funds with similar focus
|Astrec Baltic||Estonia, Harjumaa, Tallinn|
|Bezos Expeditions||Mercer Island, United States, Washington|
|Digital Technology Supercluster||British Columbia, Canada, Vancouver|
|Guangzhou Zexian Touzi Hehuo Qiye||-|
|MAGIX||Nevada, Reno, United States|
|MOBILE WORLD CAPITAL||Barcelona, Catalonia, Spain|
|National Grid Partners (NGP)||California, San Francisco, United States|
|Netflix||California, Los Gatos, United States|
|Oliphans Capital||India, Maharashtra, Mumbai|
|Pangaea Impact Investments||Austinmer, Australia, New South Wales|
|Plug and Play Japan||Japan, Tokyo|
|Shanghai Resource Property||China, Shanghai|
|Shenwan Hongyuan||China, Shanghai|
|Suzhou Aerfa Investment Management Center||China, Jiangsu, Suzhou|
|TAO Investments||Derby, England, United Kingdom|
|Vistaar Investment Advisors||India, Maharashtra, Mumbai|
|$60M||01 Jun 2021||Virginia, United States|
|$20M||22 Oct 2020||Tel Aviv District|
|$25M||12 Dec 2019||Virginia, United States|
|$16M||10 Oct 2017||Tel Aviv District|
Kyma Medical Technologies
|$10M||01 Oct 2013||North District|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.